“동래립카페🍋 〈OPdal030.COM≥오피달리기 💪🏻🐶동래스파💫동래휴게텔😽동래아로마📺동래출장안마🎀동래출장안마💨동래OP🚀”的搜索结果，显示 321-330 项，共有 17058 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to find out more about certain markers of immune suppression in people with kidney tumors (whether the tumors are ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... ≥ 60ml/min). Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer. Jacksonville, Fla., Rochester, Minn., Scottsdale ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... ≥ 60ml/min). Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer. Jacksonville, Fla., Rochester, Minn., Scottsdale ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to find out more about the side effects of the CAR-T therapy called IC19/1563 and what dose of IC19/1563 is safe ...

8. 前列腺活检- 妙佑医疗国际

   在前列腺活检期间，医生用针头从前列腺中采集一些组织样本。该程序由专攻泌尿系统和男性性器官的医生（泌尿科医生）进行。 如果初步检查（例如 ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...